Antibiotic resistance of bacterial biofilms.
By Niels Høiby, T. Bjarnsholt, M. Givskov, Søren Molin, O. Ciofu. International Journal of Antimicrobial Agents, 2010
3,118 citations recorded by the source corpus.
A biofilm is a structured consortium of bacteria embedded in a self-produced polymer matrix consisting of polysaccharide, protein and DNA. Bacterial biofilms cause chronic infections because they show increased tolerance to antibiotics and disinfectant chemicals as well as resisting phagocytosis and other components of the body's defence system. The persistence of, for example, staphylococcal infections related to foreign bodies is due to biofilm formation. Likewise, chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is caused by biofilm-growing mucoid strains. Characteristically, gradients of nutrients and oxygen exist from the top to the bottom of biofilms and these gradients are associated with decreased bacterial metabolic activity and increased doubling times of the bacterial cells; it is these more or less dormant cells that are responsible for some of the tolerance to antibiotics. Biofilm growth is associated with an increased level of mutations as well as with quorum-sensing-regulated mechanisms. Conventional resistance mechanisms such as chromosomal beta-lactamase, upregulated efflux pumps and mutations in antibiotic target molecules in bacteria also contribute to the survival of biofilms. Biofilms can be prevented by early aggressive antibiotic prophylaxis or therapy and they can be treated by chronic suppressive therapy. A promising strategy may be the use of enzymes that can dissolve the biofilm matrix (e.g. DNase and alginate lyase) as well as quorum-sensing inhibitors that increase biofilm susceptibility to antibiotics.
Subfields: Molecular Biology, Molecular Medicine, Periodontics
View Paper: https://www.semanticscholar.org/paper/84be95a445ceda85a63a53e7f7ede8d586bd4725
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Molecular Medicine
In Periodontics
- T. Bjarnsholt
- R. Vasudevan
- L. Hall-Stoodley
- K. Poole
- Christopher J Jones
- D. Wozniak
- D. Lebeaux
- D. Limoli
Citations in the corpus
- ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. (2015, background): “Chronic infections are characterized by persistent and progressing pathology, mainly due to the inflammatory response surrounding the biofilm [6].”
- Bacterial Biofilms: Development, Dispersal, and Therapeutic Strategies in the Dawn of the Postantibiotic Era (2013, background): “Combined, these attributes make biofilm bacteria up to 1000-fold more tolerant and/or resistant to antibiotics than planktonic cells (Hoiby et al. 2010).”
- Bacterial Extracellular Polysaccharides in Biofilm Formation and Function (2015, background): “While diffusion may not be prevented, it may be delayed enough to induce expression of genes that mediate tolerance (85) or be neutralized by enzymes within the matrix before reaching the bacterial cells (86, 87).”
- Biofilms: Microbial Cities of Scientific Significance (2014, background): “In fact, significance of quorum sensing in the coordination of bacterial biofilms has been confirmed by various demonstrative studies [142].”
- Multi-species biofilms: living with friendly neighbors. (2012, background): “In particular, biofilms exhibit increased resistance to chemical disinfection, antimicrobial therapy, and human immune responses (Costerton et al., 1999; Hall-Stoodley et al., 2004; Hoiby et al., 2010).”
- The role of bacterial biofilms in chronic infections (2013, background): “The denominator of these chronic infections are an extreme tolerance and resistance to antimicrobial agents and a capacity to evade the host defences (I, II, IV, V, VI, VII, VIII, IX, XI, XII, XIII) (65).”
- Pseudomonas Aeruginosa: Resistance to the Max (2011, background): “aeruginosa biofilm growth and one that is particularly relevant in a clinical context is marked resistance to antimicrobial agents (Davies and Bilton, 2009; Hoiby et al., 2010).”
- ColR-ColS signalling system and transposition of Tn4652 in the adaptation of Pseudomonas putida (2010, background): “P. aeruginosa is the best described bacterium with regards to quorum sensing (Bjarnsholt et al., 2010), in vitro biofilm formation (Schobert and Tielen, 2010) and the development of antibiotic tolerance (Hoiby et al., 2010).”
- Resistance of bacterial biofilms to disinfectants: a review (2011, background): “resistance to antibiotics (Stewart and Costerton 2001; Stewart 2002; Fux et al. 2005; Hoiby et al. 2010), there”
- Horizontal Gene Exchange in Environmental Microbiota (2011, background): “…July 2011 | Volume 2 | Article 158 | 7 formation is linked to the pathology of many infectious diseases, and biofilms are notoriously difficult to eradicate because of the increased level of resistance to antibiotics (Stewart and Costerton, 2001; Anderson and O’Toole, 2008; Høiby et al., 2010a).”
- Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies (2021, background): “Biofilms are resistant to antibiotics and disinfectants and impervious to phagocytosis, and tolerate the body’s immune system mainly because of self-produced EPS [98].”